ID   FA83H_HUMAN             Reviewed;        1179 AA.
AC   Q6ZRV2; A0JLS2; Q8N4W0;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   28-JUN-2023, entry version 134.
DE   RecName: Full=Protein FAM83H {ECO:0000305};
GN   Name=FAM83H {ECO:0000312|HGNC:HGNC:24797};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 275-1179.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 861-1179.
RC   TISSUE=Placenta, and Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1003, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [5]
RP   FUNCTION, TISSUE SPECIFICITY, AND INVOLVEMENT IN AI3A.
RX   PubMed=18252228; DOI=10.1016/j.ajhg.2007.09.020;
RA   Kim J.-W., Lee S.-K., Lee Z.H., Park J.-C., Lee K.-E., Lee M.-H.,
RA   Park J.-T., Seo B.-M., Hu J.C.-C., Simmer J.P.;
RT   "FAM83H mutations in families with autosomal-dominant hypocalcified
RT   amelogenesis imperfecta.";
RL   Am. J. Hum. Genet. 82:489-494(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-523; SER-647; SER-785 AND
RP   SER-1003, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-647; SER-881; THR-883;
RP   SER-892; SER-903; SER-936; SER-945; SER-1003; SER-1024 AND SER-1025, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-523; SER-914 AND SER-1003,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-465; SER-523; SER-647;
RP   SER-759; SER-785; SER-870; SER-881; SER-892; SER-903; SER-914; SER-936;
RP   SER-945; SER-1003; THR-1040 AND SER-1048, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION, INTERACTION WITH CSNK1A1 AND KRT18, SUBCELLULAR LOCATION, REGION,
RP   AND MUTAGENESIS OF PHE-251 AND PHE-274.
RX   PubMed=23902688; DOI=10.1242/jcs.129684;
RA   Kuga T., Kume H., Kawasaki N., Sato M., Adachi J., Shiromizu T.,
RA   Hoshino I., Nishimori T., Matsubara H., Tomonaga T.;
RT   "A novel mechanism of keratin cytoskeleton organization through casein
RT   kinase Ialpha and FAM83H in colorectal cancer.";
RL   J. Cell Sci. 126:4721-4731(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-513; SER-514; SER-516;
RP   SER-523; SER-647; SER-667; SER-785; SER-870; SER-881; SER-892; SER-903;
RP   SER-914; SER-925; SER-936; SER-1003; SER-1025 AND SER-1147, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-523; THR-756; SER-813;
RP   SER-914; SER-1003 AND SER-1068, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   VARIANT AI3A CYS-557.
RX   PubMed=26142250; DOI=10.1016/j.archoralbio.2015.06.016;
RA   Urzua B., Martinez C., Ortega-Pinto A., Adorno D., Morales-Bozo I.,
RA   Riadi G., Jara L., Plaza A., Lefimil C., Lozano C., Reyes M.;
RT   "Novel missense mutation of the FAM83H gene causes retention of amelogenin
RT   and a mild clinical phenotype of hypocalcified enamel.";
RL   Arch. Oral Biol. 60:1356-1367(2015).
CC   -!- FUNCTION: May play a major role in the structural organization and
CC       calcification of developing enamel (PubMed:18252228). May play a role
CC       in keratin cytoskeleton disassembly by recruiting CSNK1A1 to keratin
CC       filaments. Thereby, it may regulate epithelial cell migration
CC       (PubMed:23902688). {ECO:0000269|PubMed:18252228,
CC       ECO:0000269|PubMed:23902688}.
CC   -!- SUBUNIT: Interacts with CSNK1A1; recruits CSNK1A1 to keratin filaments.
CC       Interacts with KRT18 and probably other keratins.
CC       {ECO:0000269|PubMed:23902688}.
CC   -!- INTERACTION:
CC       Q6ZRV2; P48729: CSNK1A1; NbExp=11; IntAct=EBI-2556538, EBI-1383726;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:23902688}. Note=Colocalizes with keratin filaments.
CC       {ECO:0000269|PubMed:23902688}.
CC   -!- TISSUE SPECIFICITY: Expressed in the tooth follicle.
CC       {ECO:0000269|PubMed:18252228}.
CC   -!- DISEASE: Amelogenesis imperfecta 3A (AI3A) [MIM:130900]: An autosomal
CC       dominant hypomineralized form of amelogenesis imperfecta, a defect of
CC       enamel formation. AI3A is characterized by enamel of normal thickness
CC       but soft and with cheesy consistency. Enamel is lost from tooth soon
CC       after eruption. {ECO:0000269|PubMed:18252228,
CC       ECO:0000269|PubMed:26142250}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the FAM83 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC87207.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC105219; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK127960; BAC87207.1; ALT_INIT; mRNA.
DR   EMBL; BC007264; AAH07264.1; -; mRNA.
DR   EMBL; BC033256; AAH33256.1; -; mRNA.
DR   CCDS; CCDS6410.2; -.
DR   RefSeq; NP_940890.3; NM_198488.3.
DR   RefSeq; XP_005250946.1; XM_005250889.3.
DR   AlphaFoldDB; Q6ZRV2; -.
DR   SMR; Q6ZRV2; -.
DR   BioGRID; 130292; 156.
DR   IntAct; Q6ZRV2; 63.
DR   MINT; Q6ZRV2; -.
DR   STRING; 9606.ENSP00000373565; -.
DR   iPTMnet; Q6ZRV2; -.
DR   PhosphoSitePlus; Q6ZRV2; -.
DR   SwissPalm; Q6ZRV2; -.
DR   BioMuta; FAM83H; -.
DR   DMDM; 296439349; -.
DR   CPTAC; CPTAC-367; -.
DR   CPTAC; CPTAC-368; -.
DR   EPD; Q6ZRV2; -.
DR   jPOST; Q6ZRV2; -.
DR   MassIVE; Q6ZRV2; -.
DR   MaxQB; Q6ZRV2; -.
DR   PaxDb; Q6ZRV2; -.
DR   PeptideAtlas; Q6ZRV2; -.
DR   ProteomicsDB; 68170; -.
DR   Antibodypedia; 14675; 55 antibodies from 13 providers.
DR   DNASU; 286077; -.
DR   Ensembl; ENST00000388913.4; ENSP00000373565.3; ENSG00000180921.7.
DR   Ensembl; ENST00000612192.2; ENSP00000478790.1; ENSG00000273889.2.
DR   GeneID; 286077; -.
DR   KEGG; hsa:286077; -.
DR   MANE-Select; ENST00000388913.4; ENSP00000373565.3; NM_198488.5; NP_940890.4.
DR   UCSC; uc064rej.1; human.
DR   AGR; HGNC:24797; -.
DR   CTD; 286077; -.
DR   DisGeNET; 286077; -.
DR   GeneCards; FAM83H; -.
DR   HGNC; HGNC:24797; FAM83H.
DR   HPA; ENSG00000180921; Tissue enhanced (esophagus, skin).
DR   MalaCards; FAM83H; -.
DR   MIM; 130900; phenotype.
DR   MIM; 611927; gene.
DR   neXtProt; NX_Q6ZRV2; -.
DR   OpenTargets; ENSG00000180921; -.
DR   Orphanet; 100032; Hypocalcified amelogenesis imperfecta.
DR   PharmGKB; PA144596434; -.
DR   VEuPathDB; HostDB:ENSG00000180921; -.
DR   eggNOG; ENOG502QW7K; Eukaryota.
DR   GeneTree; ENSGT00940000159342; -.
DR   HOGENOM; CLU_009734_0_0_1; -.
DR   InParanoid; Q6ZRV2; -.
DR   OMA; GCHGEDT; -.
DR   OrthoDB; 4260995at2759; -.
DR   PhylomeDB; Q6ZRV2; -.
DR   TreeFam; TF330777; -.
DR   PathwayCommons; Q6ZRV2; -.
DR   SignaLink; Q6ZRV2; -.
DR   BioGRID-ORCS; 286077; 46 hits in 1155 CRISPR screens.
DR   GeneWiki; FAM83H; -.
DR   GenomeRNAi; 286077; -.
DR   Pharos; Q6ZRV2; Tbio.
DR   PRO; PR:Q6ZRV2; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q6ZRV2; protein.
DR   Bgee; ENSG00000180921; Expressed in lower esophagus mucosa and 93 other tissues.
DR   ExpressionAtlas; Q6ZRV2; baseline and differential.
DR   Genevisible; Q6ZRV2; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:1990254; F:keratin filament binding; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW.
DR   GO; GO:0045104; P:intermediate filament cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0044380; P:protein localization to cytoskeleton; IMP:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   CDD; cd09188; PLDc_FAM83H_N; 1.
DR   Gene3D; 3.30.870.10; Endonuclease Chain A; 1.
DR   InterPro; IPR012461; FAM83_N.
DR   InterPro; IPR041996; PLDc_FAM83H_N.
DR   PANTHER; PTHR16181:SF28; PROTEIN FAM83B-RELATED; 1.
DR   PANTHER; PTHR16181; UNCHARACTERIZED; 1.
DR   Pfam; PF07894; FAM83; 1.
DR   SUPFAM; SSF56024; Phospholipase D/nuclease; 1.
PE   1: Evidence at protein level;
KW   Amelogenesis imperfecta; Biomineralization; Cytoplasm; Cytoskeleton;
KW   Disease variant; Phosphoprotein; Reference proteome.
FT   CHAIN           1..1179
FT                   /note="Protein FAM83H"
FT                   /id="PRO_0000324488"
FT   REGION          1..286
FT                   /note="Mediates interaction with CSNK1A1 and is required
FT                   for FAM83H activity in keratin cytoskeleton organization"
FT                   /evidence="ECO:0000269|PubMed:23902688"
FT   REGION          484..577
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          636..669
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          830..1026
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1047..1084
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1143..1165
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        561..576
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        832..850
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        863..877
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        885..902
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        911..926
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        996..1010
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         465
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         513
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         514
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         516
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         523
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         647
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         667
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         756
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         759
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         785
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         813
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         870
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         881
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         883
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         892
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         894
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q148V8"
FT   MOD_RES         903
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         914
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         925
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         936
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         945
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         1003
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         1009
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q148V8"
FT   MOD_RES         1024
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         1025
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         1040
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         1048
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         1068
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         1147
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VARIANT         201
FT                   /note="Q -> H (in dbSNP:rs9969600)"
FT                   /id="VAR_062189"
FT   VARIANT         557
FT                   /note="G -> C (in AI3A; mild form; dbSNP:rs312262803)"
FT                   /evidence="ECO:0000269|PubMed:26142250"
FT                   /id="VAR_073954"
FT   MUTAGEN         251
FT                   /note="F->A: No effect on interaction with CSNK1A1 and
FT                   function in keratin cytoskeleton organization."
FT                   /evidence="ECO:0000269|PubMed:23902688"
FT   MUTAGEN         274
FT                   /note="F->A: Decreased interaction with CSNK1A1 and loss of
FT                   function in keratin cytoskeleton organization."
FT                   /evidence="ECO:0000269|PubMed:23902688"
FT   CONFLICT        605
FT                   /note="E -> V (in Ref. 2; BAC87207)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1179 AA;  127122 MW;  D35A1822D8E517F0 CRC64;
     MARRSQSSSQ GDNPLAPGYL PPHYKEYYRL AVDALAEGGS EAYSRFLATE GAPDFLCPEE
     LEHVSRHLRP PQYVTREPPE GSLLDVDMDG SSGTYWPVNS DQAVPELDLG WPLTFGFQGT
     EVTTLVQPPP PDSPSIKDEA RRMIRSAQQV VAVVMDMFTD VDLLSEVLEA AARRVPVYIL
     LDEMNAQHFL DMADKCRVNL QHVDFLRVRT VAGPTYYCRT GKSFKGHVKE KFLLVDCAVV
     MSGSYSFMWS FEKIHRSLAH VFQGELVSSF DEEFRILFAQ SEPLVPSAAA LARMDAYALA
     PYAGAGPLVG VPGVGAPTPF SFPKRAHLLF PPPREEGLGF PSFLDPDRHF LSAFRREEPP
     RMPGGALEPH AGLRPLSRRL EAEAGPAGEL AGARGFFQAR HLEMDAFKRH SFATEGAGAV
     ENFAAARQVS RQTFLSHGDD FRFQTSHFHR DQLYQQQYQW DPQLTPARPQ GLFEKLRGGR
     AGFADPDDFT LGAGPRFPEL GPDGHQRLDY VPSSASREVR HGSDPAFAPG PRGLEPSGAP
     RPNLTQRFPC QAAARPGPDP APEAEPERRG GPEGRAGLRR WRLASYLSGC HGEDGGDDGL
     PAPMEAEAYE DDVLAPGGRA PAGDLLPSAF RVPAAFPTKV PVPGPGSGGN GPEREGPEEP
     GLAKQDSFRS RLNPLVQRSS RLRSSLIFST SQAEGAAGAA AATEKVQLLH KEQTVSETLG
     PGGEAVRSAA STKVAELLEK YKGPARDPGG GAGAITVASH SKAVVSQAWR EEVAAPGAVG
     GERRSLESCL LDLRDSFAQQ LHQEAERQPG AASLTAAQLL DTLGRSGSDR LPSRFLSAQS
     HSTSPQGLDS PLPLEGSGAH QVLHNESKGS PTSAYPERKG SPTPGFSTRR GSPTTGFIEQ
     KGSPTSAYPE RRGSPVPPVP ERRSSPVPPV PERRGSLTLT ISGESPKAGP AEEGPSGPME
     VLRKGSLRLR QLLSPKGERR MEDEGGFPVP QENGQPESPR RLSLGQGDST EAATEERGPR
     ARLSSATANA LYSSNLRDDT KAILEQISAH GQKHRAVPAP SPGPTHNSPE LGRPPAAGVL
     APDMSDKDKC SAIFRSDSLG TQGRLSRTLP ASAEERDRLL RRMESMRKEK RVYSRFEVFC
     KKEEASSPGA GEGPAEEGTR DSKVGKFVPK ILGTFKSKK
//
